STARTING ON OCTOBER 5TH, DR. PETER AMENTA WILL BECOME THE NEW JOSLIN PRESIDENT AND CEO. WHERE PREVIOUS CEO JOHN BROOKS BACKGROUND WAS AS A BUSINESSMAN AND ENTREPRENEUR, AMENTA IS A LONG-TERM CLINICIAN AND RESEARCH SCIENTIST. A FEW HIGHLIGHTS ON HIS BACKGROUND:
- Currently a Professor of Pathology and Laboratory Medicine at Rutgers Robert Wood Johnson Medical School
- Over a 20 year career, he held a number of administrative positions at Robert Wood Johnson, including Chief of Staff and Dean of the Medical School.
- He is regarded as an expert microscopist and immunohistochemist, and is widely published.
A change in leadership such as this signals a shift in strategic direction. However, to date, there is no statement on the key reason for the change in leadership nor has their been a statement from the board of directors about what changes that want to achieve with this change.
